1127-29-3 Usage
General Description
2,2,4,4-tetramethylcyclobutane-1,3-dione dioxime is a chemical compound that is often used in the mining industry as a chelating agent for metal ions. It is a white, crystalline solid with the molecular formula C8H16N2O2 and a molar mass of 172.22 g/mol. 2,2,4,4-tetramethylcyclobutane-1,3-dione dioxime has the ability to form stable complexes with metal ions such as copper, cobalt, and nickel, making it useful in the extraction and purification of these metals from ores. Additionally, 2,2,4,4-tetramethylcyclobutane-1,3-dione dioxime is also used in analytical chemistry for the determination and quantification of metal ions in various samples. However, it is important to handle this compound with care as it may present health hazards if not properly handled.
Check Digit Verification of cas no
The CAS Registry Mumber 1127-29-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,1,2 and 7 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1127-29:
(6*1)+(5*1)+(4*2)+(3*7)+(2*2)+(1*9)=53
53 % 10 = 3
So 1127-29-3 is a valid CAS Registry Number.
InChI:InChI=1/C8H14N2O2/c1-7(2)5(9-11)8(3,4)6(7)10-12/h11-12H,1-4H3/b9-5-,10-6+
1127-29-3Relevant articles and documents
NOVEL CYP17 INHIBITORS/ANTIANDROGENS
-
Page/Page column 32, (2015/01/07)
Compounds of formula (I), wherein R1 to R8 A, B, Z1 and Z2 are as defined in the claims and pharmaceutically acceptable salts and esters thereof are disclosed. The compounds of formula (I) possess utility as androgen receptor antagonists (inhibitors) and/or cytochrome P450 monooxygenase 17a-hydroxylase/17,20-lyase (CYP17) inhibitors. The compounds are useful as medicaments in the treatment of cancer, particularly prostate cancer, and other androgen dependent conditions and diseases where androgen antagonism is desired.
